Analysis of the years of life lost burden values for the United Kingdom on the Y-axis compared to a recent report of the same cancer types for the United States [10], including lung cancer values. (PDF 103 kb
Detailed Figures of SMR development by cancer sites and age groups. Development of age standardized ...
Table S2. Estimated population attributable factors (2015, 2025) and standardized attributable cases...
Tumor cost from oxygen consumption increase. Additional details of the calculation of tumor cost fro...
The research funding to years of life lost ratios for United Kingdom data presented in Table 2 on th...
Analysis of the research funding to years of life lost ratios for United Kingdom data presented in T...
Analysis of a comparison of the percentage differences in research funding (Y-axis) and years of lif...
A: Distributions of health care costs of cancer patients at the last three months of life from rural...
Proportion of publications with an author giving a UK industry address and proportion with an author...
Table S1. Adjusted≠ all- cause mortality hazards ratios. Table S2. Age adjusted mortality rates, str...
Overview of assessments including details per country. This table contains all assessments included ...
Number and percentage of lung cancer patients who underwent tumor molecular testing. (XLSX 60 kb
Table S1. Countries included in the analysis, by geographical region a (NÂ =â83). Table S3. Relati...
Figure S1. Hierarchy of preferred methodology for generation of HSUVs for different HTA agencies. (P...
A: Distributions of health care costs of cancer patients from being diagnosed with cancer to dying b...
Percentage of patients of the top ten biomarkers at each level of evidence in each tumor type. Level...
Detailed Figures of SMR development by cancer sites and age groups. Development of age standardized ...
Table S2. Estimated population attributable factors (2015, 2025) and standardized attributable cases...
Tumor cost from oxygen consumption increase. Additional details of the calculation of tumor cost fro...
The research funding to years of life lost ratios for United Kingdom data presented in Table 2 on th...
Analysis of the research funding to years of life lost ratios for United Kingdom data presented in T...
Analysis of a comparison of the percentage differences in research funding (Y-axis) and years of lif...
A: Distributions of health care costs of cancer patients at the last three months of life from rural...
Proportion of publications with an author giving a UK industry address and proportion with an author...
Table S1. Adjusted≠ all- cause mortality hazards ratios. Table S2. Age adjusted mortality rates, str...
Overview of assessments including details per country. This table contains all assessments included ...
Number and percentage of lung cancer patients who underwent tumor molecular testing. (XLSX 60 kb
Table S1. Countries included in the analysis, by geographical region a (NÂ =â83). Table S3. Relati...
Figure S1. Hierarchy of preferred methodology for generation of HSUVs for different HTA agencies. (P...
A: Distributions of health care costs of cancer patients from being diagnosed with cancer to dying b...
Percentage of patients of the top ten biomarkers at each level of evidence in each tumor type. Level...
Detailed Figures of SMR development by cancer sites and age groups. Development of age standardized ...
Table S2. Estimated population attributable factors (2015, 2025) and standardized attributable cases...
Tumor cost from oxygen consumption increase. Additional details of the calculation of tumor cost fro...
DOI
Add to ORKG